InvestorsHub Logo
Followers 33
Posts 2911
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Sunday, 10/18/2020 2:30:49 PM

Sunday, October 18, 2020 2:30:49 PM

Post# of 155
Based on papers, such as these [1,2], and IPHA's monalizumab showing activity in humans, the company should move an anti-NKG2A CAR-NK cell product forward in my view [3].

Refs:
1 https://www.cell.com/cell/fulltext/S0092-8674(18)31322-9
2 https://www.cell.com/cell/fulltext/S0092-8674(18)31381-3
3 https://www.jci.org/articles/view/123955
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTX News